Disclosures for "Structural and functional connectome alterations across King’s stages in amyotrophic lateral sclerosis")
-
Dr. Spinelli has nothing to disclose.
-
Miss Ghirelli has nothing to disclose.
-
Silvia Basaia has nothing to disclose.
-
Ms. Cividini has nothing to disclose.
-
Nilo Riva has nothing to disclose.
-
Dr. Russo has nothing to disclose.
-
The institution of Elisa Canu has received research support from Italian Ministry of Health .
-
Dr. Castelnovo has nothing to disclose.
-
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
-
Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.